Una Recomendación de No Hacer es una indicación de abandonar una práctica clínica de escaso valor. El escaso valor lo determina el hecho de que la práctica no reporte ningún beneficio conocido para los pacientes y/o les ponga en riesgo de sufrir daños y además pueda suponer un derroche de recursos, sanitarios y/o sociales.
Las Recomendaciones de NO Hacer incluidas en el Catálogo son las que cumplen todos estos criterios.
Para solicitar la inclusión en el Catálogo, es preciso cumplimentar el formulario.
Ver más información sobre la Iniciativa NO Hacer
https://portal.guiasalud.es/wp-content/uploads/2025/03/rnh-184_d.pdf
Grupo de trabajo del OPBE del uso adecuado de pruebas y suplementos de vitamina D en población general. Recomendaciones de uso adecuado de pruebas y suplementos de vitamina D en población general. Madrid: Ministerio de Sanidad; Santiago de Compostela: Agencia Gallega para la Gestión del Conocimiento en Salud (ACIS), Unidad de Asesoramiento Científico-técnico, Avalia-t; 2021.
Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, McCartney CR et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2024;00:1–41. https://doi.org/10.1210/clinem/dgae290.
US Preventive Services Task Force; Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(14):1436-42.
Kahwati LC, LeBlanc E, Weber RP, Giger K, Clark R, Suvada K, Guisinger A, Viswanathan M. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021;325(14):1443-63.
Institute of Medicine. Dietary Reference Intakes for Calcium antd Vitamin D. The National Academies Press; 2011. doi:10.17226/ 13050.
Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018 Nov;6(11):847-858.
Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019 Jan 3;380(1):33-44.
Etienne Cavalier, Konstantinos Makris, Annemieke C Heijboer, Markus Herrmann, Jean-Claude Souberbielle. Vitamin D: Analytical Advances, Clinical Impact, and Ongoing Debates on Health Perspectives. Clin Chem. 2024, 70(9):1104-1121. doi: 10.1093/clinchem/hvae056.
Andrea Giustina, John P Bilezikian, Robert A Adler, Giuseppe Banfi, Daniel D Bikle, Neil C Binkley, et al. Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows. Endocr Rev. 2024, 45(5):625-654. doi: 10.1210/endrev/bnae009.
https://portal.guiasalud.es/wp-content/uploads/2025/06/rnh-187_d.pdf
Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016 Jul 4;7(7):CD010502. doi: 10.1002/14651858.CD010502.pub2.
Piñeiro Pérez R, Álvez González F, Baquero-Artigao F, Cruz Cañete M, de la Flor I Bru J, Fernández Landaluce A, García Vera C, Hijano Bandera F, Pérez Cánovas C, Silva Rico JC; Grupo Colaborador de Faringoamigdalitis Aguda en Pediatría. Actualización del documento de consenso sobre el diagnóstico y tratamiento de la faringoamigdalitis aguda. An Pediatr (Engl Ed). 2020 Sep;93(3):206.e1-206.e8. Spanish. doi: 10.1016/j.anpedi.2020.05.004.
https://portal.guiasalud.es/wp-content/uploads/2025/03/rnh-185_d.pdf
A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology. J Allergy Clin Immunol Pract. 2021. Fleischer DM, Chan ES, Venter C, Spergel JM, Abrams EM, Stukus D, Groetch M, Shaker M, Greenhawt. Guía de Práctica Clínica. doi: 10.1016/j.jaip.2020.11.002.
Alimentación saludable en la primera infancia. 2022, Generalitat de Catalunya. Departamento de Salud. Documento elaborado por: Agencia de Salud Pública de Cataluña (ASPCAT) Barcelona, DL: B 21061-2022. Guía de Práctica Clínica.
Appropriate age range for introduction of complementary feeding into an infant's diet. 2019. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Jacqueline Castenmiller, Stefaan de Henauw, Karen-Ildico Hirsch-Ernst, John Kearney, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marco Vinceti, Jean-Louis Bresson, Mathilde Kersting, Hildegard Przyrembel, Céline Dumas, Ariane Titz, Dominique Turck. Scientific Opinion. https://doi.org/10.2903/j.efsa.2019.5780
Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses. Logan K., Bahnson H.T., Ylescupidez A., Beyer K., Bellach J., Campbell D.E., et al: Allergy 2023. Ensayo clínico. DOI:10.1111/all.15597
Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trial Håvard Ove Skjerven, Anine Lie, Riyas Vettukattil, Eva Maria Rehbinder, Marissa LeBlanc, Anna Asarnoj, Kai-Håkon Carlsen, Åshild Wik Despriee, Martin Färdig, Sabina Wärnberg Gerdin, Berit Granum, Hrefna Katrín Gudmundsdóttir, Guttorm Haugen, Gunilla Hedlin, Geir Håland, Christine Monceyron Jonassen, Linn Landrø, Caroline-Aleksi Olsson Mägi, Inge Christoffer Olsen, Knut Rudi, Carina Madelen Saunders, Marius Kurås Skram, Anne Cathrine Staff, Cilla Söderhäll, Sandra G Tedner, Sigve Aadale, Hilde Aaneland, Björn Nordlund, Karin C Lødrup Carlsen. 2022. Ensayo Clínico. DOI: 10.1016/S0140-6736(22)00687-0
Tuballa A, Connell D, Smith M, Dowsett C, O'Neill H, Albarqouni L. Introduction of allergenic food to infants and allergic and autoimmune conditions: a systematic review and meta-analysis. BMJ Evid Based Med. 2024 Mar 21;29(2):104-113. doi: 10.1136/bmjebm-2023-112445.
https://portal.guiasalud.es/wp-content/uploads/2025/04/rnh-186_d.pdf
Evidence-based Guidelines From ESPGHAN and NASPGHAN for Helicobacter pylori Infection in Children. 2011. Sibylle Koletzko, Nicola L. Jones, Karen J. Goodman, Benjamin Gold, Marion Rowland, Samy Cadranel, Sonny Chong, Richard B. Colletti, Thomas Casswall, Yoram Elitsur, Jeannette Guarner, Nicolas Kalach, Armando Madrazo, Francis Megraud, Giuseppina Oderda, on Behalf of the H pylori Working Groups of ESPGHAN and NASPGHAN. Clinical Guidelines, Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/MPG.0b013e3182227e90.
Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents First published: 15 August 2024. Matjaž Homan, Nicola L. Jones, Patrick Bontems, Matthew W. Carroll, Steven J. Czinn, Benjamin D. Gold, Karen Goodman, Paul R. Harris, Robert Jerris, Nicolas Kalach, Michal Kori, Francis Megraud, Marion Rowland, Marta Tavares, on behalf of ESPGHAN/NASPGHAN. Practice Guidelines, Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12314.
https://portal.guiasalud.es/wp-content/uploads/2025/08/rnh_11_188.pdf
https://www.labtestsonline.es/tests/tasa-de-filtrado-glomerular
(Se solicita en las personas con enfermedad renal crónica (ERC) conocida y en los casos de diabetes o hipertensión arterial, ya que estas enfermedades pueden provocar lesiones renales.)
https://www.nefrologiaaldia.org/es-articulo-insuficiencia-renal-aguda-317
(Posteriormente, han aparecido dos modificaciones importantes de esta clasificación: la del grupo Acute Kidney Injury Network (AKIN) en 2007 [6], donde se obvian los criterios de caída del filtrado glomerular (fundamentado en la inconveniencia de emplear ecuaciones de regresión para estimar el filtrado
glomerular en situaciones en las que no exista una situación de equilibrio) y sólo se mantienen la elevación de la creatinina y la disminución en la diuresis; y la propuesta en 2012 por la Kidney Disease Improving Global Outcomes (K-DIGO) en su guía de práctica clínica de la IRA)
https://kdigo.org/guidelines/acute-kidney-injury/
(The influence of SCr or eGFR criteria on AKI staging needs to be further investigated. The use of different relative and absolute SCr increments or eGFR decrements at different time points and with differently ascertained baseline values requires further exploration and validation in various populations.)
https://portal.guiasalud.es/wp-content/uploads/2025/08/rnh_15_189.pdf
Khodayar-Pardo P, Miguez-Navarro MC, Martín Espín I; Analgesia and Sedation Working Group of the Spanish Society of Pediatric Emergency Medicine. Actions to Avoid in Pain Management and Sedoanalgesia Procedures in Pediatric Emergencies. Pediatr Emerg Care. 2024 Apr 1;40(4):e23-e29. doi: 10.1097/PEC.0000000000003053.
Guerrero Márquez G, Miguez Navarro C, Sánchez García I, et al; Grupo de Analgesia y Sedación de la Sociedad Española de Urgencias de Pediatría (GTAS-SEUP), Sociedad Española de Urgencias de Pediatría (GTAS-SEUP). Protocolos Diagnósticos y Terapéuticos en Urgencias Pediátricas: Manejo del dolor en
urgencias pediátricas [Internet]. 4ª ed. 2024 [acceso noviembre 2024]. Disponible en: https://seup.org/wpcontent/uploads/2024/04/28_Dolor_urgencias_4ed.pdf.
Storch de Gracia Calvo P. Evaluación de la intensidad del dolor. En: Miguez Navarro MC. Manual de manejo del dolor y procedimientos de sedoanalgesia en urgencias pediátricas. ERGON; 2018. p. 83-97.
Nieto Gabucio N. Neurofisiología y fisiopatología del dolor. En: Míguez Navarro MC, Alonso Salas MT, de Ceano-Vivas la Calle M, Fernández Santervás Y, García González S, Guerrero Márquez G, Serrano Ayestarán O. Manejo del dolor y procedimientos de sedoanalgesia en urgencias pediátricas. ERGON; 2018. p. 74-78.
Jukić M, Puljak L. Legal and Ethical Aspects of Pain Management. Acta Med Acad. 2018 May;47(1):18-26. doi: 10.5644/ama2006-124.211.
Matson KL, Johnson PN, Tran V, et al. Opioid use in children. J Pediatr Pharmacol Ther. 2019;24:72–75.
Friedrichsdorf SJ. Multimodal pediatric pain management (part 2). Pain Manag. 2017 May;7(3):161-166. doi: 10.2217/pmt-2016-0051.
https://portal.guiasalud.es/wp-content/uploads/2025/08/rnh_16_190_d.pdf
Martínez Campos L, Pérez-Albert P, Ferres Ramis L, et al.; en representación del Grupo de trabajo de Infecciones Bacterianas de la Sociedad Española de Infectología Pediátrica (SEIP); Grupo de Soporte de la Sociedad Española de Hematología y Oncología Pediátrica (SEHOP); Grupo de trabajo de Infección Fúngica Invasiva de la Sociedad Española de Infectología Pediátrica (SEIP). Documento de consenso de manejo de neutropenia febril en el paciente pediátrico oncohematológico de la Sociedad Española de Infectología Pediátrica (SEIP) y la Sociedad Española de Hematología y Oncología Pediátrica (SEHOP). An Pediatr (Engl Ed). 2023 Jun;98(6):446-459. doi: 10.1016/j.anpede.2023.03.010.
van der Velden WJFM, Herbers AHE, Netea MG, Blijlevens NMA. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167:441-52.
Zecha JAEM, Raber-Durlacher JE, Laheij AMGA, Westermann AM, de Lange J, Smeele LE. The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma. Front Oral Health. 2022;3:940044
Mattei D, Baretta V, Mazzariol A, Maccacaro L, Balter R, Zaccaron A, et al. Characteristics and Outcomes of Bloodstream Infections in a Tertiary-Care Pediatric Hematology-Oncology Unit: A 10-Year Study. J Clin Med. 2022;11:880.
Cennamo F, Masetti R, Largo P, Argentiero A, Pession A, Esposito S. Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy. Children. 2021;8:1086.
Anderson K, Bradford N, Edwards R, Nicholson J, Lockwood L, Clark J. Addressing the barriers to optimal management of febrile neutropenia in children with cancer. Eur J Oncol Nurs. 2020 Apr;45:101719. DOI: 10.1016/j.ejon.2019.101719.
Woods EJ, Walker LE, Heaton HA, Scanlan-Hanson LN, Finley JL, Olson OJ, Khan SP, Mannenbach MS. Improving timely antibiotic administration for pediatric oncology patients with neutropenic fever seen in the Emergency Department. Mayo Clin Proc Innov Qual Outcomes. 2022 Nov 5;6(6):597-604. DOI: 10.1016/j.mayocpiqo.2022.10.002.
Gonzalez ML, Aristizabal P, Loera-Reyna A, et al. The golden hour: sustainability and clinical outcomes of adequate time to antibiotic administration in children with cancer and febrile neutropenia in Northwestern Mexico. JCO Glob Oncol. 2021 May;7:659-670. DOI: 10.1200/GO.20.00578.
Burns B, Hartenstein M, Lin A, et al. Optimizing time to antibiotic administration in children with possible febrile neutropenia through quality improvement methodologies. Pediatric Quality and Safety 4(6):p e236, November/December 2019. DOI: 10.1097/pq9.0000000000000236
https://portal.guiasalud.es/wp-content/uploads/2025/08/rnh_25_191_d2.pdf
Roppolo LP, Morris DW, Khan F, Downs R, Metzger J, Carder T, et al. Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation). J Am Coll Emerg Physicians Open [Internet]. 2020;1(5):898–907. Disponible en: http://dx.doi.org/10.1002/emp2.12138
Córcoles Martínez D, Ramos Perdigues S, González Fresnedo AM, Bellsolà González M, Malagón Amor Á, Martín López LM. Verbal de-escalation to reduce the use of mechanical restraint during nonvoluntary ambulance transfers. Emergencias.2023 Apr;35(2):97-102. Disponible en: http://dx.doi.org/10.55633/s3me/e076.2023
Garriga M, Pacchiarotti I, Kasper S, Zeller SL, Allen MH, Vázquez G, Baldaçara L, San L, McAllister-Williams RH, Fountoulakis KN, Courtet P, Naber D, Chan EW, Fagiolini A, Möller HJ, Grunze H, Llorca PM, Jaffe RL, Yatham LN, Hidalgo-Mazzei D, Passamar M, Messer T, Bernardo M, Vieta E. Assessment and management of agitation in psychiatry: Expert consensus. World J Biol Psychiatry. 2016;17(2):86-128. doi: 10.3109/15622975.2015.1132007.
Gottlieb M, Long B, Koyfman A. Approach to the Agitated Emergency Department Patient. J Emerg Med. 2018 Apr;54(4):447-457. doi: 10.1016/j.jemermed.2017.12.049. Epub 2018 Feb 1.
Richmond JS, Berlin JS, Fishkind AB, Holloman GH Jr, Zeller SL, Wilson MP, Rifai MA, Ng AT. Verbal De-escalation of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup. West J Emerg Med. 2012 Feb;13(1):17-25. doi: 10.5811/westjem.2011.9.6864.
Vieta E, Garriga M, Cardete L, Bernardo M, Lombraña M, Blanch J, Catalán R, Vázquez M, Soler V, Ortuño N, Martínez-Arán A. Protocol for the management of psychiatric patients with psychomotor agitation. BMC Psychiatry. 2017 Sep 8;17(1):328. doi: 10.1186/s12888-017-1490-0.
Saidinejad M, Foster AA, Santillanes G, Li J, Wallin D, Barata IA, Joseph M, Rose E, Cheng T, Waseem M, Berg K, Hooley G, Ruttan T, Shahid S, Lam SHF, Amanullah S, Lin S, Heniff MS, Brown K, Gausche-Hill M; ACEP Pediatric Emergency Medicine Committee. Strategies for optimal management of pediatric acute agitation in emergency settings. J Am Coll Emerg Physicians Open. 2024 Aug 23;5(4):e13255. doi: 10.1002/emp2.13255.
Foster AA, Saidinejad M, Li J. Approach to acute agitation in the pediatric emergency department. Curr Opin Pediatr. 2024 Jun 1;36(3):245-250. doi: 10.1097/MOP.0000000000001337. Epub 2024 Jan 31.
Fernández-Gallego V, Casal Angulo C, Sorribes del Castillo J, Sinisterra Aquilino JA. Contención del paciente agitado. Formación Médica Continuada en Atención Primaria. 2020;27(10). DOI: https://doi.org/10.1016/j.fmc.2020.03.013.
https://portal.guiasalud.es/wp-content/uploads/2025/08/rnh_26_192_d.pdf
Faria JCP, Victorino CA, Sato MA. Epinephrine in pediatric cardiorespiratory arrest: when and how much? Einstein (Sao Paulo). 2020 Jan 27;18:eRW5055. doi: 10.31744/einstein_journal/2020RW5055.
Andersen LW, Berg KM, Saindon BZ, Massaro JM, Raymond TT, Berg RA, Nadkarni VM, Donnino MW; American Heart Association Get With the Guidelines–Resuscitation Investigators.Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest. JAMA. 2015 Aug 5;314(8):802-10. doi: 10.1001/jama.2015.9678.
Matsuyama T, Komukai S, Izawa J, Gibo K, Okubo M, Kiyohara K, Kiguchi T, Iwami T, Ohta B, Kitamura T. Pre-Hospital Administration of Epinephrine in Pediatric Patients With Out-of-Hospital Cardiac Arrest. J Am Coll Cardiol. 2020 Jan 21;75(2):194-204. doi: 10.1016/j.jacc.2019.10.052.
Raymond TT, Praestgaard A, Berg RA, Nadkarni VM, Parshuram CS, American Heart Association’s Get With The Guidelines- Resuscitation I. The association of hospital rate of delayed epinephrine administration with survival to discharge for pediatric nonshockable in-hospital cardiac arrest. Pediatr Crit Care Med 2019;20:405 _16, doi:http://dx.doi.org/10.1097/ PCC.0000000000001863.
Lin YR, Li CJ, Huang CC, et al. Early epinephrine improves the stabilization of initial post-resuscitation hemodynamics in children with non-shockable out-of-hospital cardiac arrest. Front Pediatr 2019;7:220, doi:http://dx.doi.org/10.3389/fped.2019.00220.
Hansen M, Schmicker RH, Newgard CD, et al. Time to epinephrine administration and survival from nonshockable out-of-hospital cardiac arrest among children and adults.Circulation 2018;137:2032 _40, doi:http://dx.doi.org/10.1161/ CIRCULATIONAHA.117.033067.
Maconochie IK, Aickin R, Hazinski MF, et al. Pediatric life support: 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation 2020;156:A120 _55, doi:http://dx. doi.org/10.1016/j.resuscitation.2020.09.013.
https://portal.guiasalud.es/wp-content/uploads/2025/08/rnh_28_193_d.pdf
Van de Voorde P, Turner NM, Djakow J, et al. European Resuscitation Council Guidelines 2021: Paediatric Life Support. Resuscitation. 2021 Apr;161:327-87. DOI: 10.1016/j.resuscitation.2021.02.015.
Marin JR, Abo AM, Arroyo AC, et al. Pediatric emergency medicine point-of-care ultrasound: summary of the evidence. Crit Ultrasound J. 2016 Dec;8(1):16. DOI: 10.1186/s13089-016-0049-5.
Huis In't Veld MA, Allison MG, Bostick DS, et al. Ultrasound use during cardiopulmonary resuscitation is associated with delays in chest compressions. Resuscitation. 2017 Oct;119:95-98. DOI: 10.1016/j.resuscitation.2017.07.021.
Via G, Hussain A, Wells M, et al. International evidence-based recommendations for focused cardiac ultrasound. J Am Soc Echocardiogr 2014;27(7):683.e1-683.e33.